Synergistic effects of photodynamic therapy with HPPH and gemcitabine in pancreatic cancer cell lines

Lasers in Surgery and Medicine

Volumn 44, Issue 9, 2012, Pages 755-761

  Sun, Gang ^a,b   Anderson, Marlys A ^a   Gorospe, Emmanuel C ^a   Leggett, Cadman L ^a   Lutzke, Lori S ^a   Wong Kee Song, Louis M ^a   Levy, Michael ^a   Wang, Kenneth K ^a  

^a MAYO CLINIC   (United States)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

gemcitabine; pancreatic cancer; photodynamic therapy

Indexed keywords

2 [1 HEXYLOXYETHYL] 2 DEVINYL PYROPHEOPHORBIDE; GEMCITABINE; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ARTICLE; CELL DEATH; CYTOTOXICITY; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOTHERAPY; PANCREAS CANCER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DEATH; CELL LINE, TUMOR; CHLOROPHYLL; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HUMANS; PANCREATIC NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 84867948210     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.22073     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ,. Cancer statistics, 2008. CA Cancer J Clin 2008; 58 (2): 71-96.
2. Li D, Xie K, Wolff R, Abbruzzese JL,. Pancreatic cancer. Lancet 2004; 363 (9414): 1049-1057.
3. Hidalgo M,. Pancreatic cancer. N Engl J Med 2010; 362 (17): 1605-1617.
4. Regine WF, Winter KA, Abrams RA, Safran H, Hoffman JP, Konski A, Benson AB, Macdonald JS, Kudrimoti MR, Fromm ML, Haddock MG, Schaefer P, Willett CG, Rich TA,. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial. JAMA 2008; 299 (9): 1019-1026.
5. Herman JM, Swartz MJ, Hsu CC, Winter J, Pawlik TM, Sugar E, Robinson R, Laheru DA, Jaffee E, Hruban RH, Campbell KA, Wolfgang CL, Asrari F, Donehower R, Hidalgo M, Diaz LA, Jr, Yeo C, Cameron JL, Schulick RD, Abrams R,. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: Results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol 2008; 26 (21): 3503-3510.
6. Burris HA III, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD,. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial. J Clin Oncol 1997; 15 (6): 2403-2413.
7. Cunningham D, Chau I, Stocken DD, Valle JW, Smith D, Steward W, Harper PG, Dunn J, Tudur-Smith C, West J, Falk S, Crellin A, Adab F, Thompson J, Leonard P, Ostrowski J, Eatock M, Scheithauer W, Herrmann R, Neoptolemos JP,. Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. J Clin Oncol 2009; 27 (33): 5513-5518.
8. Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, Au HJ, Murawa P, Walde D, Wolff RA, Campos D, Lim R, Ding K, Clark G, Voskoglou-Nomikos T, Ptasynski M, Parulekar W,. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2007; 25 (15): 1960-1966.
9. Chan HH, Nishioka NS, Mino M, Lauwers GY, Puricelli WP, Collier KN, Brugge WR,. EUS-guided photodynamic therapy of the pancreas: A pilot study. Gastrointest Endosc 2004; 59 (1): 95-99.
10. Yusuf TE, Matthes K, Brugge WR,. EUS-guided photodynamic therapy with verteporfin for ablation of normal pancreatic tissue: A pilot study in a porcine model (with video). Gastrointest Endosc 2008; 67 (6): 957-961.
11. Bown SG, Rogowska AZ, Whitelaw DE, Lees WR, Lovat LB, Ripley P, Jones L, Wyld P, Gillams A, Hatfield AW,. Photodynamic therapy for cancer of the pancreas. Gut 2002; 50 (4): 549-557.
12. Hawes RH, Xiong Q, Waxman I, Chang KJ, Evans DB, Abbruzzese JL,. A multispecialty approach to the diagnosis and management of pancreatic cancer. Am J Gastroenterol 2000; 95 (1): 17-31.
13. Allison R,. Photosensitizers in clinical PDT. Photodiagn Photodyn Ther 2004; 1 (1): 27-42.
14. Overholt BF, Lightdale CJ, Wang KK, Canto MI, Burdick S, Haggitt RC, Bronner MP, Taylor SL, Grace MG, Depot M,. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: International, partially blinded, randomized phase III trial. Gastrointest Endosc 2005; 62 (4): 488-498.
15. Bellnier DA, Greco WR, Loewen GM, Nava H, Oseroff AR, Dougherty TJ,. Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IX. Lasers Surg Med 2006; 38 (5): 439-444.
16. Bellnier DA, Greco WR, Loewen GM, Nava H, Oseroff AR, Pandey RK, Tsuchida T, Dougherty TJ,. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients. Cancer Res 2003; 63 (8): 1806-1813.
17. Celli JP, Solban N, Liang A, Pereira SP, Hasan T,. Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines. Lasers Surg Med 2011; 43 (7): 565-574.
18. Ayaru L, Wittmann J, MacRobert AJ, Novelli M, Bown SG, Pereira SP,. Photodynamic therapy using verteporfin photosensitization in the pancreas and surrounding tissues in the Syrian golden hamster. Pancreatology 2007; 7 (1): 20-27.
19. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C, Gutberlet K, Kettner E, Schmalenberg H, Weigang-Koehler K, Bechstein WO, Niedergethmann M, Schmidt-Wolf I, Roll L, Doerken B, Riess H,. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial. JAMA 2007; 297 (3): 267-277.
20. Liu CD, Kwan D, Saxton RE, McFadden DW,. Hypericin and photodynamic therapy decreases human pancreatic cancer in vitro and in vivo. J Surg Res 2000; 93 (1): 137-143.
21. Mikvy P, Messman H, MacRobert AJ, Pauer M, Sams VR, Davies CL, Stewart JC, Bown SG,. Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC). Br J Cancer 1997; 76 (6): 713-718.
22. Nuutinen PJ, Chatlani PT, Bedwell J, MacRobert AJ, Phillips D, Bown SG,. Distribution and photodynamic effect of disulphonated aluminium phthalocyanine in the pancreas and adjacent tissues in the Syrian golden hamster. Br J Cancer 1991; 64 (6): 1108-1115.
23. Samkoe KS, Chen A, Rizvi I, O'Hara JA, Hoopes PJ, Pereira SP, Hasan T, Pogue BW,. Imaging tumor variation in response to photodynamic therapy in pancreatic cancer xenograft models. Int J Radiat Oncol Biol Phys 2010; 76 (1): 251-259.
24. Xie Q, Jia L, Liu YH, Wei CG,. Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer in vivo. World J Gastroenterol 2009; 15 (6): 737-741.
25. Henderson BW, Bellnier DA, Greco WR, Sharma A, Pandey RK, Vaughan LA, Weishaupt KR, Dougherty TJ,. An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy. Cancer Res 1997; 57 (18): 4000-4007.
26. Pandey RK, Bellnier DA, Smith KM, Dougherty TJ,. Chlorin and porphyrin derivatives as potential photosensitizers in photodynamic therapy. Photochem Photobiol 1991; 53 (1): 65-72.
27. Bellnier DA, Greco WR, Nava H, Loewen GM, Oseroff AR, Dougherty TJ,. Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy. Cancer Chemother Pharmacol 2006; 57 (1): 40-45.
28. Long J, Zhang Y, Yu X, Yang J, LeBrun DG, Chen C, Yao Q, Li M,. Overcoming drug resistance in pancreatic cancer. Expert Opin Ther Targets 2011; 15 (7): 817-828.
29. Giovannetti E, Mey V, Danesi R, Mosca I, Del Tacca M,. Synergistic cytotoxicity and pharmacogenetics of gemcitabine and pemetrexed combination in pancreatic cancer cell lines. Clin Cancer Res 2004; 10 (9): 2936-2943.
30. Mlkvy P, Messmann H, Pauer M, Stewart JC, Millson CE, MacRobert AJ, Bown SG,. Distribution and photodynamic effects of meso-tetrahydroxyphenylchlorin (mTHPC) in the pancreas and adjacent tissues in the Syrian golden hamster. Br J Cancer 1996; 73 (12): 1473-1479.
31. Seshadri M, Bellnier DA, Vaughan LA, Spernyak JA, Mazurchuk R, Foster TH, Henderson BW,. Light delivery over extended time periods enhances the effectiveness of photodynamic therapy. Clin Cancer Res 2008; 14 (9): 2796-2805.